Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-3066
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

An Update on the Biology of RAS/RAF Mutations in Colorectal Cancer

Current Colorectal Cancer Reports
HepatologyOncologyGastroenterology
2011English

Prognostic Value of CD133 and SOX2 in Advanced Cancer

Journal of Oncology
Oncology
2019English

K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value

ISRN Molecular Biology
2012English

Prognostic Value of IRF-2 Expression in Colorectal Cancer

Oncotarget
Oncology
2017English

Prognostic Significance of K-Ras Mutations in Pancreatic Cancer: A Meta-Analysis

World Journal of Surgical Oncology
SurgeryOncology
2016English

Prognostic Significance of CD133 and Ezrin Expression in Colorectal Carcinoma

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

The Prognostic Value of CSCs Biomarker CD133 in NSCLC: A Meta-Analysis

Oncotarget
Oncology
2016English

The Prognostic Value of P53 Positive in Colorectal Cancer: A Retrospective Cohort Study

Tumor Biology
MedicineCancer Research
2017English

Effects of RAF Inhibitors on PI3K/AKT Signalling Depend on Mutational Status of the RAS/RAF Signalling Axis

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy